Patient-reported resilience associated with outcomes after HCT
the ONA take:
Among long-term survivors of hematopoetic celltransplantation (HCT), patient-reported resilience is independently associated with health and psychosocial outcomes, according to a recent study published online ahead of print in Cancer.
Researchers led by Abby Rosenberg, MD, MS, of the Seattle Children’s Hospital observed 4,643 adult survivors of HCT as part of the annual Fred Hutchinson Cancer Research Center (FHCRC) post-transplant survivorship survey from July 2013 to June 2014.
The survey included patient-reported health and functional status as well as instruments that assessed psychosocial outcomes such as the 10-item Connor-Davidson Resilience scale, the Posttraumatic Growth Inventory, and the Cancer and Treatment Distress measure. Among those patients, 1,823 (39%) responded after a single mailing and subsequent reminder letter. Median age was 59 years and 52.5% of patients were male.
The researchers found that lower patient-reported resilience was associated with chronic graft-versus-host disease of higher severity, lower performance scores, missing work for health reasons, and permanent disability.
Upon adjusting for demographic and health characteristics, lower patient-reported resilience scores showed higher odds of having psychological distress as well as being in the lowest quartile for mental health-related quality of life.
“Future studies must determine whether interventions can bolster resilience and improve survivorship outcomes,” the authors concluded.
Among long-term survivors of hematopoetic cell transplantation (HCT), patient-reported resilience is independently associated with outcomes.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|